Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Quipt Home Medical Corp (QIPT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/05/2025: QIPT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $3.6
1 Year Target Price $3.6
| 3 | Strong Buy |
| 1 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -63.99% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/05/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 106.10M USD | Price to earnings Ratio - | 1Y Target Price 3.6 |
Price to earnings Ratio - | 1Y Target Price 3.6 | ||
Volume (30-day avg) 5 | Beta 0.49 | 52 Weeks Range 1.35 - 3.27 | Updated Date 12/7/2025 |
52 Weeks Range 1.35 - 3.27 | Updated Date 12/7/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.24 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -4.23% | Operating Margin (TTM) -4.41% |
Management Effectiveness
Return on Assets (TTM) -1.04% | Return on Equity (TTM) -9.51% |
Valuation
Trailing PE - | Forward PE 56.82 | Enterprise Value 184724621 | Price to Sales(TTM) 0.45 |
Enterprise Value 184724621 | Price to Sales(TTM) 0.45 | ||
Enterprise Value to Revenue 0.77 | Enterprise Value to EBITDA 3.87 | Shares Outstanding 43443972 | Shares Floating 31067653 |
Shares Outstanding 43443972 | Shares Floating 31067653 | ||
Percent Insiders 23.25 | Percent Institutions 49.44 |
Upturn AI SWOT
Quipt Home Medical Corp
Company Overview
History and Background
Quipt Home Medical Corp. was founded in 2013. It has grown through a series of strategic acquisitions and organic expansion to become a leading provider of in-home respiratory and other durable medical equipment (DME). The company focuses on serving patients with chronic respiratory conditions, sleep apnea, and other conditions requiring home-based medical support.
Core Business Areas
- Home Respiratory Services: Provides a comprehensive suite of respiratory services, including the delivery, setup, and ongoing support for CPAP machines, oxygen concentrators, and ventilators for patients with chronic respiratory diseases such as COPD and sleep apnea.
- Durable Medical Equipment (DME): Offers a range of durable medical equipment beyond respiratory devices, catering to various home health needs.
- Ancillary Services: Includes services such as remote patient monitoring, compliance programs, and patient education to enhance care and outcomes.
Leadership and Structure
Quipt Home Medical Corp. is led by a management team with extensive experience in the healthcare and DME industries. The organizational structure is designed to support its distributed operational model, with regional hubs and local service centers managing patient care and equipment delivery.
Top Products and Market Share
Key Offerings
- CPAP Machines and Accessories: Quipt offers a wide range of Continuous Positive Airway Pressure (CPAP) machines, masks, and related accessories for the treatment of sleep apnea. Competitors include Philips Respironics, ResMed, and Fisher & Paykel Healthcare. Specific market share data for this product line is not publicly disclosed but is a significant revenue driver. A large number of patients nationwide rely on these devices for effective sleep apnea management.
- Oxygen Concentrators and Therapy: Provides portable and stationary oxygen concentrators, as well as related supplies, for patients with respiratory conditions requiring supplemental oxygen. Key competitors include Air Liquide Healthcare, Linde plc (via its healthcare division), and Chart Industries. This segment serves a substantial patient base with chronic lung diseases.
- Ventilators and Ventilator Support: Offers mechanical ventilators and associated support services for patients with severe respiratory failure, enabling them to breathe at home. Competitors include GE Healthcare, Philips Respironics, and Medtronic. This is a critical service for a segment of the company's patient population.
Market Dynamics
Industry Overview
The home medical equipment (HME) and durable medical equipment (DME) market is characterized by steady growth driven by an aging population, increasing prevalence of chronic diseases (especially respiratory and sleep disorders), and a shift towards home-based care. Reimbursement policies from Medicare, Medicaid, and private insurers play a significant role in market dynamics. The industry is competitive with both national players and regional providers.
Positioning
Quipt Home Medical Corp. is positioned as a consolidator and operator within the fragmented HME/DME market. Its competitive advantages include a strong acquisition strategy to expand its geographic reach and service offerings, a focus on operational efficiency, and a commitment to patient care and compliance. The company aims to leverage its scale to provide better service and potentially negotiate more favorable terms with suppliers and payers.
Total Addressable Market (TAM)
The total addressable market for home medical equipment and respiratory services in the US is estimated to be in the tens of billions of dollars, driven by factors like an aging demographic and the increasing incidence of chronic conditions. Quipt Home Medical Corp. is positioned to capture a growing share of this market through its strategic acquisitions and organic growth initiatives, though it represents a relatively small portion of the overall TAM at present.
Upturn SWOT Analysis
Strengths
- Strong acquisition track record for market expansion.
- Focus on chronic respiratory and sleep apnea markets with growing demand.
- Experienced management team with industry expertise.
- Scalable operational model supporting efficient service delivery.
- Growing patient base and recurring revenue streams from consumables and services.
Weaknesses
- Reliance on reimbursement from government and private payers, subject to policy changes.
- Integration challenges and costs associated with acquisitions.
- Intense competition from both large national providers and smaller regional players.
- Potential for disruptions in supply chain for medical equipment.
Opportunities
- Continued consolidation of the fragmented HME/DME market through further acquisitions.
- Expansion into new product categories and related home healthcare services.
- Leveraging technology for remote patient monitoring and telehealth integration.
- Increasing demand for home-based care due to cost-effectiveness and patient preference.
- Partnerships with healthcare systems and physician groups to drive referrals.
Threats
- Changes in healthcare reimbursement policies and rates.
- Increased regulatory scrutiny and compliance requirements.
- New entrants or disruptive technologies impacting the market.
- Economic downturns affecting healthcare spending.
- Adverse clinical outcomes or patient dissatisfaction leading to reputational damage.
Competitors and Market Share
Key Competitors
- AdaptHealth Corp. (NASDAQ: AHCO)
- LHC Group, Inc. (NASDAQ: LHCG) - Acquired by Optum (UnitedHealth Group)
- U.S. Physical Therapy, Inc. (NYSE: USPH) - Diversified services, some overlap
- Curo Group Holdings Corp. (NYSE: CURO) - Not directly comparable but a healthcare services company
Competitive Landscape
Quipt Home Medical Corp. faces intense competition from larger, established players like AdaptHealth and other diversified healthcare service providers. Its advantage lies in its agility and focus on specific niches within the HME/DME market. However, it needs to continually demonstrate efficient operations and superior patient service to compete effectively with companies that may have greater financial resources and broader service portfolios. Reimbursement rates and regulatory changes significantly impact all players.
Major Acquisitions
Various Regional HME Providers
- Year: Ongoing
- Acquisition Price (USD millions): Variable, often undisclosed individually
- Strategic Rationale: To expand geographic reach, increase patient base, add service capabilities, and achieve economies of scale.
Growth Trajectory and Initiatives
Historical Growth: Quipt Home Medical Corp. has exhibited significant historical growth, largely propelled by its strategy of acquiring smaller, regional home medical equipment providers. This has allowed for rapid expansion of its geographic footprint and customer base.
Future Projections: Future growth is projected to continue through a combination of strategic acquisitions and organic expansion. The company aims to capitalize on the increasing demand for home healthcare services and the ongoing consolidation within the HME/DME industry. Analyst projections would need to be consulted for specific growth rate estimates.
Recent Initiatives: Recent initiatives likely include further integration of acquired businesses, optimization of operational efficiencies, expansion of service offerings, and potential exploration of new geographic markets. The company may also be investing in technology to enhance patient care and operational management.
Summary
Quipt Home Medical Corp. is a growing player in the fragmented home medical equipment market, primarily focused on respiratory services. Its aggressive acquisition strategy has fueled expansion, but integration and competition remain key challenges. The company benefits from the increasing demand for home-based care and its specialized focus, but needs to carefully manage reimbursement risks and operational efficiency to sustain its growth trajectory.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company investor relations websites
- SEC filings (10-K, 10-Q)
- Industry research reports
- Financial news and analysis platforms
Disclaimers:
This JSON output is generated for informational purposes only and does not constitute financial advice. All data is based on publicly available information and may not be exhaustive or entirely up-to-date. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Quipt Home Medical Corp
Exchange NASDAQ | Headquaters Wilder, KY, United States | ||
IPO Launch date 2021-05-27 | Chairman, President & CEO Mr. Gregory J. Crawford | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 1150 | Website https://quipthomemedical.com |
Full time employees 1150 | Website https://quipthomemedical.com | ||
Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers; invasive ventilation; and home medical equipment, such as stair lifts, ramps, bath safety equipment, daily living, and ambulatory, as well as home modification solutions. It also engages in the rental and sale of medical equipment and related devices. In addition, the company offers solutions that supports patients dealing with heart and pulmonary disease, sleep apnea, reduced mobility, COPD, neuromuscular disorders, obesity, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.